The Era of Hope Meeting for the Department of Defense (DOD) Breast Cancer Research Program (BCRP)

Last Modified: January 23, 2002

Share article


Date: September 25-28, 2002
Location: Orange County Convention Center, Orlando, Florida, USA


Symposium Web Page: http://cdmrp.army.mil/bcrp/

Sponsors: US Department of Defense Congressionally Directed Medical Research Program

Objectives: To gain greater insight into breast cancer through the scientific exchange between oncology professionals and all individuals whose lives have been touched by breast cancer in some way.

Who should attend: Scientists, physicians, breast cancer survivors and advocates, policymakers, and the general public

Topics: The meeting is organized around topics and research areas including Signal Transduction, Prevention and Targets for Individualized TherapyCell Biology, Prevention, Detection and Diagnosis, Treatment, Signal Transduction, Vaccines, Imaging, Epidemiology, Behavioral, Chemoprevention, Immunology, Clinical and Experimental Therapeutics, Genetics and Molecular Biology, Pathiobiology, Endocrinology, Complementary and Alternative Medicine, Health Care Delivery, Biobehavioral Sciences

Agenda: Exact agenda TBD. The Era of Hope 2002 meeting marks the 10th anniversary of the Department of Defense (DOD) Breast Cancer Research Program (BCRP), a leader in breast cancer research funding. The meeting provides a forum for researchers in different fields and research areas to gather and share their ideas and identify promising new directions in breast cancer research. The perspectives and participation of breast cancer survivors are uniquely incorporated into the meeting. The Era of Hope meeting provides an unprecedented opportunity to highlight the contributions of DOD BCRP research grantees in pushing the boundaries and advancing discoveries in breast cancer research, and to reflect on promising, innovative avenues of research for the upcoming decade.

Registration Info: Registration is required. Additional meeting and registration information will be posted online. Registration, logistics contact: Erika Petersen at (301) 228-3128.

Fees: TBA

Continuing Education: Yes. Details will be available online.


News
Participants had regular mammography; changes parallel drop in hormone therapy use after 2002

Nov 12, 2010 - Alongside a steep decline in the use of hormone therapy, incidence of invasive breast cancer and ductal carcinoma in situ fell in older women undergoing regular mammography in 2002 to 2006, according to research published online Nov. 8 in the Journal of Clinical Oncology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More